Direxion Daily NVDA Bull... NVDU - 옵션 체인 | ADVFN

다우존스 지수

브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

등록

홈
인베스팅
ETFs
미국
NASDAQ
Direxion Daily NVDA Bull 2X ETF (NVDU)
Direxion Daily NVDA Bull 2X ETF (NVDU) 옵션

Direxion Daily NVDA Bull 2X ETF (NVDU)

56.17

-7.34

(-11.56%)

마감 07 3월 6:00AM

57.15

0.98

( 1.74% )

시간외 단일가: 9:27PM

NVDU 실시간 옵션 플로우

콜

행사 가격	매수가	매도가	최근 가격	중간 가격	가격 변동	가격 변동 %	거래량	미결제 약정	최근 거래
47.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
48.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
49.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
50.00	8.70	10.20	16.00	9.45	0.00	0.00 %	0	106	-
51.00	8.00	9.90	0.00	8.95	0.00	0.00 %	0	0	-
52.00	7.90	9.10	28.20	8.50	0.00	0.00 %	0	1	-
53.00	7.30	8.60	0.00	7.95	0.00	0.00 %	0	0	-
54.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
55.00	5.80	7.50	11.75	6.65	0.00	0.00 %	0	6	-
56.00	5.90	7.10	8.60	6.50	0.00	0.00 %	4	0	07/03/2025
57.00	5.00	6.50	6.70	5.75	-5.80	-46.40 %	29	0	07/03/2025
58.00	4.60	6.20	6.26	5.40	-4.24	-40.38 %	1	2	07/03/2025
59.00	3.90	6.00	5.30	4.95	-1.10	-17.19 %	2	2	07/03/2025
60.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
61.00	3.10	4.60	8.64	3.85	0.00	0.00 %	0	6	-
62.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
63.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
64.00	2.40	3.50	4.00	2.95	-2.60	-39.39 %	7	27	07/03/2025
65.00	2.60	3.20	6.40	2.90	0.00	0.00 %	0	162	-
66.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-

개인 투자자를 위한 전문가급 도구.

풋

행사 가격	매수가	매도가	최근 가격	중간 가격	가격 변동	가격 변동 %	거래량	미결제 약정	최근 거래
47.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
48.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
49.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
50.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
51.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
52.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
53.00	4.30	6.50	4.80	5.40	2.16	81.82 %	7	14	07/03/2025
54.00	4.00	5.40	5.00	4.70	0.00	0.00 %	0	15	-
55.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
56.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
57.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
58.00	6.10	7.90	4.70	7.00	0.00	0.00 %	0	32	-
59.00	7.50	8.50	7.26	8.00	-0.14	-1.89 %	4	4	07/03/2025
60.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
61.00	7.80	9.90	9.10	8.85	2.63	40.65 %	2	19	07/03/2025
62.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
63.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
64.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
65.00	10.70	13.00	7.72	11.85	0.00	0.00 %	0	172	-
66.00	11.40	13.50	12.40	12.45	3.50	39.33 %	1	76	07/03/2025

가장 활성
% 상승자
% 패자

기호	가격	볼륨
SUNESUNation Energy Inc	US$ 0.4423 (149.75%)	107.99M
HFBLHome Federal Bancorp Inc of Louisiana	US$ 19.85 (53.88%)	5
BBGIBeasley Broadcast Group Inc	US$ 9.99 (53.46%)	37
VTVTvTv Therapeutics Inc	US$ 25.00 (49.88%)	4
FAMIFarmmi Inc	US$ 0.3366 (47.24%)	36.53M
SYRESpyre Therapeutics Inc	US$ 13.01 (-36.54%)	69
LUNRIntuitive Machines Inc	US$ 7.23 (-35.79%)	1.63M
PROVProvident Financial Holdings Inc	US$ 11.20 (-24.78%)	18
USCBUSCB Financial Holdings Inc	US$ 14.20 (-20.89%)	12
BFINBankFinancial Corporation	US$ 10.21 (-20.48%)	25
SUNESUNation Energy Inc	US$ 0.4423 (149.75%)	107.99M
FAMIFarmmi Inc	US$ 0.3366 (47.24%)	36.53M
PSTVPlus Therapeutics Inc	US$ 1.99 (38.19%)	17.93M
CTMXCytomX Therapeutics Inc	US$ 0.8247 (33.60%)	16.1M
ICONIcon Energy Corporation	US$ 0.1601 (10.41%)	8.42M

ubueltp

ubueltp 4 분 전

As Naz is going door to door looking to sell, word is out and valuations become more internally concrete. I expect the share price to increase, as interest and expectations turns into share price increases. GLTL….it’s coming

chereb19

chereb19 4 분 전

No shares, yet you’re still churning this whiny MK soap opera? ‘Five patients aren’t thriving’? December 2024 says they’re recovering well—metastatic or not, that’s the safety win, not your pity party. ‘Underdosed’ flawing Phase 1? Spare us—FDA’s pre-subs see that India data, Phase 2’s on, safety’s

JOoa0ky

JOoa0ky 4 분 전

Not with Mark Calabria the whale hunter around.

KISSINGER

KISSINGER 5 분 전

This is a fantasy world your living here. Maybe he will merge one of his shitty horses in the shell. Or maybe he chould name one of his foals Bad Vibrations and put it in this POS. A R Merger may get an initial run but it will die fast and it will be a disaster for people buying here except on an in

RickNagra

RickNagra 5 분 전

Calling all whales.

Chip79

Chip79 5 분 전

StayHumble continues to post the same miss-leading information on a daily basis. The real facts are:

>Kevin Lamb does not work for UBQU, he is a VP at Gentell

>Long term debt has grown fom 1.1M in 2023, to 2.4M in 2024. Overall liabilities jumped from 1.6M to 4.2M

StayHumble

StayHumble 5 분 전

💹Major US Xchange✅$HCWC InfoDeck💹✅💹https://static1.squarespace.com/static/58a1d7b8893fc0b6d3e47931/t/63599cf2e6708456f8187f4c/1666817273168/HCMC_LDMicroOct2022.pdf
https://investorshub.advfn.com/uimage/uploads/2025/2/23/ijjizHCMC_screenshot_2.png
h

gladeshawk

gladeshawk 6 분 전

QS>>>Fyi on solid state batteries. QS has a chance to be the pick for VW EVs. Just a FYI.

https://www.msn.com/en-us/news/technology/anode-free-solid-state-batteries-could-provide-more-than-500-miles-of-ev-range-on-a-charge/ar-AA1AhRdK?ocid=msedgdhp&pc=DCTS&cvid=821486d608b84aaca1e9c

bucks2pennies

bucks2pennies 6 분 전

Yes can, GTCH future still a BIG can of worms! Still cannot but feel the mess is unwinding more and more each day. Progress in doing so, IMO, gives more strength to our perspective that GTCH continues to have "REAL" value in addition to their holdings of AVAI and BNIX.

It seems they

Hoskuld

Hoskuld 7 분 전

I don't invest that way and I assume other people don't invest that way either. Tesla is a car company. Maybe it wants to be a robot company. The car company is worth $40b. The robot company is worth the other $$850b? I don't think so.

Truthsocial

Truthsocial 8 분 전

FINAL WARNING.....ON RDGL

https://www.nolo.com/legal-encyclopedia/libel-vs-slander-different-types-defamation.html

IRON_CROSS

IRON_CROSS 8 분 전

Long road left to hoe from here, but at least the .07-.09 gaps finally got filled. That's one helluva chart 👇️ ... nasty.

https://investorshub.advfn.com/uimage/uploads/2025/3/7/lkecqScreen_Shot_2025-03-07_at_7.19.56_AM.png

https://investorshub.advfn.com/uimage/

StayHumble

StayHumble 8 분 전

wow💹$DJT launching $100+💹PE Ratio is +475 Facts Matter🇺🇸Maybe

StayHumble

StayHumble 9 분 전

💹$HYCM💹on the SILVER screen✅the GoldenGlobe✅💹

$7.00 or Nothing

$7.00 or Nothing 9 분 전

IB_ is a SHE?

Wow - I can't imagine it - sorry - it does not work for me...

rodman

rodman 10 분 전

The race to market is on and the big boy Pfizer cannot bully UEEC!
CelluSTAT Hemostatic Gauze IS the proven hemostasis product.
Gel and foam will need to jump many hurdles and pass many FDA obstacles!

https://clinicaltrials.gov/search?cond=hemostat&viewType=Table&checkSp

tulla236a

tulla236a 10 분 전

are there cracks starting in the dam? if they can tap into finra and the dtcc records too that would destroy those 2.

https://x.com/xMarketNews/status/1897755482753765633

SC8

Apparently human trial standards are lower in India than USA. FDA was emphatic that effective dosages be worked out before they would authorize human trials. It appears RDGL is still messing with dosages and Indian authorities gave green light to phase 2 anyway.

Again, we know FDA i

Roofus

Roofus 12 분 전

They are compared to if Betaglue had been treating them.

$7.00 or Nothing

$7.00 or Nothing 12 분 전

Making it CLEAR once and for all:
when a company is bought or merges with another company, do all partnerships with financial implication need to be disolved?
Not necessarily! When a company is bought or merges with another, the fate of its financial partnerships depends on several fac

work-n-hard

work-n-hard 12 분 전

MLGO: In https://investorshub.advfn.com/uimage/uploads/2025/3/7/cvtwlScreenshot_2025-03-07_at_07-30-46_MLGO_SharpCharts_StockCharts.com.png

europa7

europa7 12 분 전

"...usdc on @hedera is live on @cryptocom..."

HBAR Foundation
@HBAR_foundation
Mar 7, 2025
https://x.com/HBAR_foundation/status/1897947502436888594

"...usdc on @hedera is live on @cryptocom..."

https://x.com/cryptocom
*&#x

elks

elks 13 분 전

What y’all say where is a good play at?

stocktowatch

stocktowatch 13 분 전

$CVM CEL-SCI Reports Fiscal Q1 2025 Financial Results: Multikine Shows Pre-Surgical Tumor Elimination and Regression in Just 3 Weeks
https://finance.yahoo.com/news/cel-sci-reports-fiscal-q1-133000994.html

KISSINGER

KISSINGER 13 분 전

ZENADRONE Benefits from Chinese tariffs?? You need to be in business to benefit. ZENA is only in the business of fluff, hype and lies.

This POS is going to buite it hard just like EPAZD and all the other PASSLEY deals before it. Arent you embarassed Shaun?? Probably not since you hav

Direxion Daily NVDA Bull...

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관